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Prion diseases are subacute neuro-degenerative diseases that affect 
humans and a range of domestic and free-
ranging animal species. These diseases 
are characterized by the accumulation 
of PrPSc, an abnormally folded isoform 
of the cellular prion protein (PrPC), in 
affected tissues. The pathology during 
prion disease appears to occur almost 
exclusively within the central nervous 
system. The extensive neurodegenera-
tion which occurs ultimately leads to the 
death of the host. An intriguing feature 
of the prion diseases, when compared 
with other protein-misfolding diseases, is 
their transmissibility. Following periph-
eral exposure, some prion diseases accu-
mulate to high levels within lymphoid 
tissues. The replication of prions within 
lymphoid tissue has been shown to be 
important for the efficient spread of dis-
ease to the brain. This article describes 
recent progress in our understanding of 
the cellular mechanisms that influence 
the propagation of prions from periph-
eral sites of exposure (such as the lumen 
of the intestine) to the brain. A thorough 
understanding of these events will lead 
to the identification of important targets 
for therapeutic intervention, or alterna-
tively, reveal additional processes that 
influence disease susceptibility to periph-
erally-acquired prion diseases.
Prion diseases (transmissible spongi-
form encephalopathies) are sub-acute 
neurodegenerative diseases that affect 
both humans and animals. During 
prion disease aggregations of PrPSc, an 
abnormally folded isoform of the cel-
lular prion protein (PrPC), accumulate 
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in affected tissues. Prion infectivity co-
purifies with PrPSc and is considered by 
some to constitute the major component 
of the infectious agent.1,2 Many prion 
diseases, including natural sheep scra-
pie, bovine spongiform encephalopathy 
(BSE), chronic wasting disease (CWD) 
in cervids and variant Creutzfeldt-Jakob 
disease (vCJD) in humans, are acquired 
peripherally such as by oral exposure. 
The transmissible nature of many prions 
diseases is an intriguing feature, when 
compared with other protein-misfolding 
diseases. However, recent data have 
started to challenge the opinion that this 
is restricted to prion diseases. Peripherally 
applied β-amyloid has been reported to 
induce cerebral β-amyloidosis in recipi-
ent APP23 transgenic mice.3 Similarly, 
pathological α-synuclein aggregates from 
the brain of a patient with Lewy body dis-
ease when injected into A53T α-synuclein 
transgenic mice induced the aggrega-
tion of endogenous α-synuclein in their 
enteric nervous systems.4
After exposure, many prion diseases 
first replicate within the secondary lym-
phoid organs (SLO) as they make their 
journey from the site of infection to the 
central nervous system (CNS) (a process 
termed “neuroinvasion”).5-9 Prion rep-
lication within SLO is critical for effi-
cient neuroinvasion.5-7,10 From lymphoid 
tissues, prions appear to subsequently 
invade the CNS by spreading throughout 
the peripheral nervous system,11 although 
hematogenous spread cannot be entirely 
excluded.
Due to the availability of an ever 
increasing battery of immunodeficient 
and transgenic mouse, much attention in 
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of mouse Peyer’s patches.33 The intes-
tinal epithelium-specific gene Gpa33 is 
expressed highly by enteroctyes through-
out the intestine and not by Peyer’s patch 
FDC. However, IHC analysis of Peyer’s 
patches shows FDC accumulate high lev-
els of enterocyte-derived Gpa33 protein 
on their surfaces after being shed from the 
intestinal epithelium in association with 
exosomes.33
To determine whether FDC also pas-
sively acquire PrPC embryonic day 15 
spleen tissue from PrPC-deficient (Prnp-/-) 
mice or wild-type (WT) controls was 
transplanted under the kidney capsule of 
WT recipient mice.34 Within the grafted 
spleens, the stromal FDC are of donor 
Prnp-genotype, whereas the majority of 
the hematopoietically-derived cells within 
the graft (lymphocytes, leukocytes, etc.) 
and all cell lineages within the rest of 
the mouse are of host Prnp-genotype. 
If FDC do acquire PrPC from other cell 
lineages one would expect to detect PrPC 
upon the surfaces of the FDC within the 
PrPC-deficient spleens grafted into WT 
mice (Prnp-/-→WT). Grafted spleen tis-
sues within the recipient kidneys were 
analyzed by IHC 6 weeks after transplant 
and PrPC-expressing FDC were detected, 
as anticipated in the B cell follicles of the 
WT donor spleens grafted into WT recip-
ients (WT→WT). However, the FDC 
within the Prnp-/- spleens grafted into WT 
mice (Prnp-/-→WT) lacked PrPC expres-
sion indicating that FDC do not simply 
acquire PrPC from other cell populations 
(Fig. 1).34
FDC characteristically trap and retain 
native antigen on their surfaces for long 
periods in the form of immune complexes, 
consisting of antigen-antibody and/or 
complement components. FDC them-
selves express negligible levels of comple-
ment component C4 at the mRNA level, 
but the detection of large quantities of 
activated C4 protein on their surfaces by 
IHC illustrates their capacity to capture 
and retention of immune complexes.35 
Prions also appear to be acquired by FDC 
as complement-opsonized complexes.36-39 
Thus FDC may simply act as concentrat-
ing depots for prion-containing, comple-
ment-opsonized complexes.
FDC and mature B cells express 
high levels of Cr2 which encodes the 
non-hematopoietic-origin of FDC in 
order to attempt to address their role in 
prion pathogenesis. In these studies, mis-
matches were created in Prnp expression 
(which encodes PrPc) between the FDC-
containing stromal and lymphocyte- and 
leukocyte-containing hematopoietic com-
partments by grafting bone marrow cells 
from PrPC-deficient (Prnp-/-) mice into 
PrPC-expressing wild-type mice and vice 
versa.26,27 Using this approach FDC and 
all other stromal cells were derived from 
the recipient, whereas lymphocytes and 
other hematopoietic lineages were derived 
from the donor cells. Following periph-
eral exposure prion accumulation upon 
FDC was only detected in the spleens 
of mice with a Prnp-expressing stromal 
compartment.
While these studies clearly show that 
the presence of FDC is important for 
prion accumulation in the spleen, it was 
not possible to dissociate the Prnp expres-
sion status of FDC from that of the ner-
vous system and all the other stromal 
and non-hematopoietic host-cell popula-
tions.26,27 The precise identification of the 
cell populations that facilitate prion repli-
cation in SLO is important for a number of 
reasons. Prion infection can occur within 
an inflammatory PrPC-expressing stromal 
cell population at sites of chronic inflam-
mation that is phenotypically distinct 
from FDC.28 Most evidence indicates that 
FDC do not derive from hematopoietic 
precursors.18,29 However, the detection of 
donor hematopoietic cell-derived antigens 
on the surface of FDC in recipient mice 
was originally considered evidence of an 
FDC precursor cell population within 
the bone marrow.30 With hindsight these 
observations were most likely due to the 
FDC’s efficient ability to acquire exosome-
associated antigens from neighboring 
cells.31 These microvesicles enable FDC to 
passively acquire and display proteins on 
their surfaces that they do not express at 
the mRNA level.31 Both PrPC and PrPSc 
can be released from cells in association 
with exosomes.32 This suggests that FDC 
may likewise passively acquire PrPC and 
prions after their release in exosomes from 
other infected cells. The efficient ability of 
FDC to acquire exosome-associated pro-
teins on their surfaces was recently high-
lighted in a detailed ultrastructural study 
recent years has focused on how prions 
are initially transported from the site of 
infection to the SLO, and onwards into 
the CNS. This article therefore focuses on 
the pathogenesis of the acquired prion dis-
eases, and describes recent progress in our 
understanding of the cellular mechanisms 
that influence prion neuroinvasion from 
peripheral sites of exposure.
Identification of the Cellular Sites 
of Prion Replication in SLO
The stromal cells within SLO are a het-
erogenous group of non-migratory cells 
with diverse functions including the 
organization and compartmentalization 
of SLO, the formation of the extracellu-
lar matrix, the guidance and survival of 
immune cells, and the formation of con-
duits through which small lymph-borne 
antigens may be delivered to the lymph 
node parenchyma.12-15 Follicular dendritic 
cells (FDC) are an important subset of 
these stromal cells and are situated within 
the primary B-cell follicles and germinal 
centers of SLO. FDC should not be con-
fused with the bone marrow-derived clas-
sical dendritic cells (DC),16 as they are 
an entirely distinct, non-phagocytic and 
non-migratory stromal cell lineage.17,18 
In the SLO of some sheep with natural 
scrapie, cervids with CWD and patients 
with vCJD, prions accumulate first upon 
FDC as they make their journey from 
the site of infection to the CNS (a pro-
cess termed neuroinvasion).8,9,19 Many 
studies in mice have shown that prion 
accumulation upon FDC is important 
for efficient neuroinvasion after periph-
eral exposure. Furthermore, prion accu-
mulation in the spleen and subsequent 
neuroinvasion are both impeded in immu-
nodeficient mice that specifically lack 
FDC,7,20,21 or following their temporary 
de-differentiation.5,22,23
Although prion neuroinvasion from 
peripheral sites of exposure is dependent 
upon the presence of FDC in lymphoid 
tissues, it was uncertain whether these 
cells actually express PrPC and replicate 
prions. Expression cellular of PrPC is 
mandatory to sustain prion infection,24,25 
and FDC appear to express high levels 
on their cell surfaces.26,27 Some stud-
ies have exploited the mesenchymal and 
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dendrites.46 Further studies are necessary 
to determine whether these defects lead to 
subtle effects on FDC-dependent immune 
function such as impairments to antibody 
affinity maturation.
Prions Spread from SLO  
to the Brain via the Peripheral 
Nervous System
The SLO are highly innervated with sym-
pathetic neurones,47 and following rep-
lication upon FDC prions subsequently 
infect the peripheral nervous system.33 
The depletion of sympathetic nerves 
impedes prion neuroinvasion,11 indicat-
ing that following replication upon FDC, 
translocation to the CNS occurs via the 
peripheral nervous system.11,48 While the 
relative positioning of FDC to peripheral 
nerves has been shown to influence the 
rate of neuroinvasion,49 little is known of 
how the neuroinvasion actually occurs. 
Studies have also suggested that mono-
nuclear phagocytes such as classical DC 
may transfer prions directly to the nervous 
system.50-52 However, whether these cells 
do play an important role in the transfer 
of prions from the immune to the periph-
eral nervous system in vivo50 is uncertain 
since subsequent data suggested this was 
unlikely.53
M Cells: Portals for Prions  
Across the Intestinal Epithelium
The gut-associated lymphoid tissues 
(GALT) include the appendix, tonsils, 
Peyer’s patches, colonic and cecal patches 
and isolated lymphoid follicles (ILF). In 
combination with the mesenteric lymph 
nodes, these tissues help protect the 
host from gastro-intestinal infections. 
However, within days of oral prion expo-
sure early replication occurs upon FDC 
in Peyer’s patches,33 and is obligatory for 
efficient neuroinvasion.6,7 Data also show 
that FDC within tertiary lymphoid tis-
sues, such as mature ILF, are also poten-
tially important sites of prion replication 
and neuroinvasion in the intestine.7 To 
be able to replicate upon FDC in Peyer’s 
patches and ILF, the prions must first 
cross the follicle-associated epithelium 
(FAE) which overlies the mucosal sur-
face of these tissues. Many studies have 
unaffected, these data clearly show that 
FDC do not simply acquire prions follow-
ing release from other infected host cells, 
even in mice displaying clinical signs of 
prion disease in the brain.10
Ultrastructural analysis of the cellular 
compartments within which PrPSc local-
izes upon/within FDC has failed to detect 
any intracellular accumulation. Instead 
the PrPSc appears to accumulate along the 
surfaces of their dendrites, increasing in 
density as the infection proceeds.33 This 
suggests that de novo PrPSc conversion 
occurs upon the FDC surface.
The accumulation of high levels of 
PrPSc within the brain ultimately leads 
to the development of neuropathology. 
Antigens trapped on the surface of FDC 
are considered to promote the develop-
ment of high affinity antibody responses 
and to maintain immunological mem-
ory.41-45 Despite the detection of high lev-
els PrPSc upon the surfaces of FDC within 
SLO throughout almost the entire dura-
tion of the disease, no gross immunologi-
cal defect has been reported. However, 
ultrastructural analysis of prion-affected 
SLO has revealed evidence of disease-
associated morphological changes to 
FDC. These include adversely affected 
maturation cycles, abnormal dendritic 
folding and exacerbated accumulation 
of immune complexes between the FDC 
complement receptors CR2/CR1 
(CD21/35).39,40 Victoratos and colleagues 
illustrated how CD21-cre mice could be 
used to study FDC-specific gene func-
tion.40 Using this approach we recently 
created unique compound transgenic 
mice in which PrPC expression could be 
specifically “switched on” or “switched 
off” only on FDC.10 These mice where 
then used to establish whether FDC 
amplify prions, or simply acquire them 
from other infected host cells. In the first 
mouse line, PrPC-expression was switched 
on only on FDC. In the SLO of these 
mice only the FDC had the potential to 
replicate prions since they were the only 
cells in the body which expressed PrPC. 
Our data showed that the expression of 
PrPC only on FDC was sufficient to sus-
tain high levels of prion replication upon 
FDC after peripheral exposure. These 
data confirm that FDC are the critical 
sites of prion replication in SLO.
We also created a second compound 
transgenic mouse model in which PrPC 
expression was specifically “switched off” 
only on FDC. If FDC are the critical sites 
of prion replication in the spleen, then one 
would also expect this to be blocked when 
PrPC expression was ablated only on FDC. 
Our data confirmed this to be the case 
(Fig. 2). As PrPC expression in all other 
host cells (e.g., nerves) in these mice was 
Figure 1. FDC do not passively acquire PrPC from other cell types. whole embryonic day 15 spleen 
tissue from Prnp-/- mice or wild-type (wt) controls was transplanted under the kidney capsule of 
wt recipient mice. tissues were analyzed 6 weeks after transplant. FDC expressing high levels 
of PrPC were detected in the B-cell follicles of the wt donor spleens grafted into wt recipients 
(wt→wt; left-hand parts). However, no PrPC was detected upon FDC within the Prnp-/- spleens 
grafted into wt mice (Prnp-/-→wt; right-hand parts). Upper parts: scale bar = 200 μm. Lower parts: 
scale bar = 50 μm. adapted from Brown et al.34
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CD11c+ Cells Aid the Delivery  
of Prions to FDC in the GALT
Once antigens have been trancytosed by 
M cells they exit into the intraepithelial 
pocket beneath the basolateral mem-
brane where they are processed by the 
lymphocytes and mononuclear phago-
cytes (MNP, a heterogeneous population 
of macrophages and classical dendritic 
cells) 69 within it or immediately below 
in the sub-epithelial dome.59 Migratory 
bone marrow-derived classical DC are 
centrally involved in the transport of 
antigens both within Peyer’s patches and 
on into the mesenteric lymph nodes.70,71 
Classical DC characteristically internalize 
antigens and process them into short pep-
tides which they present to naïve T cells. 
Unlike macrophages, classical DC appear 
to be equipped with both degradative and 
nondegradative antigen uptake pathways 
to facilitate antigen presentation to both 
T and B cells.72,73 The ability of classical 
DC to capture and retain unprocessed 
uptake from the gut lumen into Peyer’s 
patches.
Whether prions are specifically 
acquired by M cells is uncertain. Their 
transcytosis could occur non-specifically 
via the bulk uptake of particulate antigen. 
However, molecules such as Gp2 which 
are highly and specifically expressed by 
M cells can be utilized by certain types 
of bacteria to aid their uptake.67 M cells 
also express high level of cellular PrPC 
on their surfaces highlighting a potential 
mechanism by which prions might be spe-
cifically acquired.55 However, data from 
the immunohistological tracing studies 
indicate that PrPC-deficiency throughout 
the intestinal epithelium does not impair 
PrPSc uptake from the gut lumen.33,61 
Further studies are necessary to determine 
whether other molecules on the apical sur-
face of M cells specifically bind prions, or 
whether PrPC acts as a transcytotic recep-
tor for other pathogenic microorganisms 
as suggested for the uptake of Brucella by 
macrophages.68
attempted to address how prions cross this 
specialized, single layer of epithelial cells 
bound by tight-junctions, and survive 
intact in sufficient quantities to infect the 
host. Scattered within the FAE of Peyer’s 
patches are a unique subset of epithelial 
cells termed microfold cells (M cells). 
These highly transcytotic cells enable 
the host’s immune system to sample the 
intestinal lumen and, where necessary, 
elicit an appropriate immune response.54,55 
However, the ability of M cells to mediate 
the transepithelial transfer of particulate 
antigens has been exploited by a range of 
pathogens, including bacteria and viruses, 
to enable them to gain entry into mucosal 
tissues.56-60
Data from studies in which prions were 
immunohistologically traced after oral 
exposure,61,62 or using an in vitro system 
with “M cell-like” transcytotic proper-
ties,63 suggest that M cells are the initial 
sites of prion transcytosis across the intes-
tinal epithelium. However, other studies 
using similar approaches suggested that 
this translocation occurred instead via 
enterocytes, independently of M cells.64,65 
A further study showed that while some 
uptake of PrPSc was detectable within 
M cells, the majority appeared to localize 
to, and be transcytosed by, FAE-associated 
enterocytes.33 The significance of these 
observations for prion neuroinvasion from 
the intestine was uncertain.
The tumor necrosis factor (TNF) 
superfamily member receptor activator of 
NFκB ligand (RANKL) has been shown 
to be a critical factor that induces the 
differentiation of M cells in the gut epi-
thelium and maintains them in their dif-
ferentiated state.54 Within Peyer’s patches 
RANKL is expressed by subepithelial 
stromal cells beneath the FAE and signals 
via its receptor RANK (receptor activator 
of NFκB) which is expressed by epithelial 
cells throughout the intestine. M cells can 
be specifically depleted in vivo by RANKL 
neutralization, and are absent in RANKL-
deficient mice.54 Data from recent experi-
ments utilizing RANKL neutralization to 
specifically deplete M cells show that both 
the early prion accumulation upon FDC 
in Peyer’s patches and neuroinvasion were 
blocked in their absence at the time of oral 
exposure (Fig. 3). These data suggest that 
M cells are the important sites of prion 
Figure 2. the specific ablation of PrPC expression only on FDC blocks prion replication in the 
spleen. CD21-cre mice can be used to study FDC-specific gene function.40 (a and B) Using this ap-
proach we recently created a compound transgenic mouse in which PrPC expression could be spe-
cifically “switched off” only on FDC.10 (C and E) Following peripheral prion exposure high levels of 
PrPSc accumulate upon the surfaces of FDC in the spleens of control mice. (D and F) However, prion 
replication is blocked in the spleens of mice in which PrPC expression was specifically “switched 
off” only on FDC. arrow heads in (D) show scavenged PrP within tBM. arrows in (E) show PrPSc-
positive FDC in the spleens of control mice. (a and B) scale bar = 100 μm; (C and D) scale bar = 
20 μm; (E and F) scale bar = 500 μm. adapted from McCulloch et al.
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data that depending on the context, MNP 
may act as a double-edged sword during 
prion pathogenesis. As described above, 
some MNP, perhaps those typical of clas-
sical DC, might behave as “Trojan horses” 
and provide a safe haven in which prions 
may be propagated to and within SLO. In 
contrast, highly phagocytic macrophages 
may facilitate their destruction.
Tingible body macrophages (TBM) 
are a subset of large MNP specific to the 
germinal centers of SLO. TBM charac-
teristically contain many remnants of 
phagocytised apoptotic lymphocytes in 
various states of degradation (termed 
“tingible bodies”). Increased numbers of 
disease-specific PrP-containing TBM are 
found within the B-cell follicles of prion-
affected animals.33,46 The detection of 
PrPSc only within the endosomal compart-
ments of TBM,33 suggests that these cells 
scavenge and degrade prions from infected 
FDC.10 High levels of prions rapidly accu-
mulate within the SLO within weeks of 
peripheral exposure. Following infection 
of the CNS the accumulation/replication 
of prions appears to occur exponentially 
until the death of the animal. However, 
the magnitude of the prion accumulation 
within the spleen rapidly reaches a plateau 
level which is maintained for the dura-
tion of the disease.20,26 How this plateau is 
maintained is uncertain. This may be due 
to the establishment of a competitive state 
whereby FDC act to amplify prions above 
the threshold required to achieve neuroin-
vasion, whereas macrophages act to destroy 
them.85,86 The ability of MNP to provide 
a protective response against prions is 
further illustrated when signaling path-
ways which stimulate pro-inflammatory 
responses by these cells are blocked. Prion 
accumulation in the spleen is enhanced in 
mice deficient in interferon regulatory fac-
tor 3 (IRF3), a key transcription factor of 
the MyD88-independent type I interferon 
production pathway.87 Similarly, tumor 
necrosis factor receptor 1-deficiency facili-
tates replication of RML scrapie prions 
within macrophages within SLO.21
Recent data challenge the opinion 
that M cells are major site of antigen 
transcytosis in the FAE. Ultrastructural 
analysis shows FAE enterocytes may also 
exocytose the intravacuolar contents of 
their late endosomes into the extracellular 
Tunnelling nanotubes (TNT) have 
been proposed as a novel intercellular 
conduit through which prions and other 
pathogens such as HIV, may disseminate 
intracellularly between cells.51,81 Data also 
suggest that HIV may further utilize TNT 
to evade virus-specific antibody responses 
by shuttling virus-derived immunosup-
pressive factors from infected MNP to 
B cells.82 The protein M-Sec (encoded by 
Tnfaip2) is expressed at high levels by M 
cells and MNP and functions as a key reg-
ulator of TNT formation.83 Most M cells 
within the FAE of Peyer’s patches appear to 
have a one-to-one association with MNP 
which extend their dendritic processes into 
the basolateral pockets of M cells.84 This 
tight association raises the suggestion that 
prions may also be transferred intracellu-
larly between M cells and MNP via TNT. 
It is also plausible that prions subsequently 
disseminate onwards from infected MNP 
to other cells via TNT.52
Mononuclear Phagocytes:  
A Double-edged Sword  
during Prion Pathogenesis
While the nature of the CD11c+ cells 
implicated in prion propagation remains 
to be determined, it is clear from current 
antigen,74,75 and migrate into B-cell fol-
licles suggested classical DC are plausible 
candidates for the propagation of prions to 
and within SLO.
Expression of the integrin α X (Itgax, 
CD11c) is commonly used to discriminate 
classical DC from macrophages. The use 
of transgenic mice in which CD11c+ cells 
can be specifically depleted has signifi-
cantly extended our in vivo understanding 
of the immunobiology of classical DC.76 
The depletion of CD11c+ cells prior to 
prion exposure impedes replication upon 
FDC in the draining SLO and delays neu-
roinvasion from the intestine,77 peritoneal 
cavity78 and skin.79 These data imply that 
following their transcytosis across the 
FAE by M cells,66 prions are subsequently 
propagated toward the FDC-containing 
B-cell follicles by classical DC.77 However, 
further studies are necessary to test this 
hypothesis. Our recent data illustrate 
how there is a distinct lack of absolutely 
unique cellular markers in the MNP sys-
tem, and CD11c-expression alone does 
not specifically identify classical DC.69,80 
Thus, whether the CD11c+ cells that influ-
ence prion pathogenesis are classical DC, 
or another MNP population within the 
Peyer’s patches, likewise remains to be 
determined.
Figure 3. the specific ablation of M cells blocks oral prion pathogenesis. (a and B) whole-mount 
immunostaining shows that treatment of mice with anti-raNKL-mab blocks raNKL-raNKL signal-
ing and specifically depletes M cells (GP2+ UEa-1+ cells) in the FaE of Peyer’s patches. (C and D) in 
the specific absence of M cells at the time of oral exposure prion accumulation (PrPSc, black) upon 
FDC in Peyer’s patches is blocked. adapted from Donaldson et al.66
www.landesbioscience.com Prion 327
i.v. exposed aged mice was significantly 
impaired when compared with young mice 
with most failing to develop clinical dis-
ease during their lifespans.
The effects of host age on the ability 
of FDC trap and retain immune com-
plexes are not simply due to the reduced 
expression of complement receptors, or 
reduced levels of opsonising complement 
components in the serum, since these were 
unaffected in aged mice.34 In the spleen 
the marginal zone (MZ) forms a bar-
rier around the lymphocyte-containing 
white pulp and plays an important role 
in the capture of blood-borne antigens 
and immune complexes, and facilitates 
their efficient transport to FDC.12,106 The 
B cells within the MZ continuously shuttle 
between the MZ and B-cell follicles in the 
underlying white pulp and play an impor-
tant role in the capture and transport of 
blood-borne, complement-bound antigens 
to FDC.106 Aging dramatically disturbs 
the microarchitecture of the MZ (Fig. 4), 
which impedes the delivery of immune 
complexes to FDC.34 Since prions are like-
wise considered to be acquired by FDC as 
complement-bound complexes,36-39 these 
aging-related disturbances to the MZ 
appear to impede the shuttling of prion-
containing complement-bound complexes 
to FDC. As a consequence, prion replica-
tion on FDC is reduced and neuroinva-
sion impeded.34,97
The expression of PrPC by FDC in the 
spleens of aged mice is also dramatically 
reduced.97 The mechanism responsible for 
the downregulation of PrPC expression 
on aged FDC is uncertain. The expres-
sion of PrPC by FDC in the spleen can be 
stimulated by immune complex-trapping, 
and is blocked in the absence of comple-
ment.107 Whether the reduced expression 
of PrPC by aged FDC is a consequence of 
their reduced ability to trap complement-
opsonised immune complexes remains to 
be determined.
The Presence of Prions  
in SLO and Brain  
Does Not Always Correlate
No prion-specific preclinical diagnostics 
are currently available compounding the 
problems for the assessment of disease-
incidence, treatment and eradication. 
also influencing the susceptibility to some 
acquired prion diseases.
Host age significantly impairs immune 
function. This raised the suggestion that 
the effects of aging on the host’s immune 
system may also influence the pathogen-
esis of many acquired prion diseases such 
as natural sheep scrapie, CWD and vCJD 
which replicate in SLO prior to neuroin-
vasion. This hypothesis is consistent with 
data from a comparative study of Peyer’s 
patches from sheep, cattle and humans 
that suggested an age-related association 
between Peyer’s patch development and 
susceptibility to natural prion disease.92 In 
aged (600-d-old) mice FDC are impaired, 
and in contrast to those in young adult 
spleens, appear atrophic and have lim-
ited capacity to trap and retain immune 
complexes. As a consequence, aged mice 
elicit poor antibody responses.93-96 Studies 
using aged mice that show that coincident 
with the effects of host age on FDC sta-
tus, the early replication of ME7 scrapie 
prions upon FDC in the spleen was sig-
nificantly impaired.97 Furthermore, fol-
lowing peripheral exposure (via oral and 
intraperitoneal routes), none of the aged 
mice developed clinical prion disease dur-
ing their lifespans, although some dis-
played histopathological signs of disease in 
their brains. A similar effect of host age on 
susceptibility to peripheral infection with 
RML scrapie prions has also been reported 
in reference 98. Data also show that the 
underdeveloped or reduced functional 
status of FDC in neonatal mice likewise 
coincides with impaired prion neuroinva-
sion following peripheral exposure.99,100 
Whether a similar correlation is observed 
in natural prion infections remains to be 
determined?
Four cases of vCJD have also been 
reported in recipients of blood or blood 
products derived from vCJD-infected 
donors.101-104 Interestingly, three of these 
cases were reported in elderly patients: two 
cases preclinical;102,104 one case clinical.101 
This raised the possibility that intravenous 
(i.v.) exposure may be more efficient in the 
elderly when compared with other periph-
eral routes of exposure. Using an aged 
mouse model, data show that, as in young 
adult mice, the i.v. route is more efficient 
than other peripheral routes of prion expo-
sure.105 However, disease pathogenesis in 
space of the SED.33 This potentially rep-
resents a novel, previously unrecognized 
important component of the normal 
machinery for antigen presentation in the 
GALT. These data also raise the ques-
tion of whether the route through which 
antigens are transcytosed across the FAE 
fundamentally influences the nature of 
the immune response induced to those 
antigens? Do antigens which are sampled 
via M cells induce protective immune 
responses, whereas a more tolerogenic 
response is induced after transfer via FAE 
enterocytes? After being exocytosed by 
FAE enterocytes PrPSc appeared to be sub-
sequently detected within the endosomal 
compartments of more macrophage-like 
MNP cells rather than classical DC.33 
In the absence of M cells after RANKL-
neutralization, prion neuroinvasion from 
the GALT is blocked.66 Although possible 
effects of RANKL-neutralization on FAE 
enterocytes cannot be entirely excluded 
in the above study,66 it is tempting to 
speculate that following their transcytosis 
by M cells or FAE enterocytes the fate of 
the prions also differs: transfer via FAE 
enterocytes, leading to phagocytosis and 
destruction by MNP in the sub-epithe-
lial dome; transfer via M cells, facilitat-
ing uptake and transport by classical DC 
toward FDC within the B-cell follicles.
Aging Dramatically Influences 
Prion Pathogenesis within SLO
The ingestion of BSE contaminated meat 
products is most likely the original source 
of vCJD in humans.88 During the UK BSE 
epidemic almost 500,000 infected cattle 
were likely to have been slaughtered for 
human consumption.89 Despite the proba-
ble widespread exposure of the UK human 
population to the BSE agent, most clinical 
cases of vCJD have occurred almost exclu-
sively in young adults (median age at onset 
of disease = 26 y; median age at death = 
28 y). These data starkly contrast those for 
sporadic CJD which have predominantly 
occurred in the elderly (median age at 
onset of disease = 67 y).90 The suggestion 
that this age-related incidence of vCJD 
was simply due to exposure to greater 
levels of BSE through dietary preference 
has not been substantiated.91 This indi-
cated that other age-related factors were 
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prion disease in the elderly population.34,97 
Although many prion-exposed aged mice 
displayed histopathological signs of prion 
disease in their brains, prions were absent 
in the spleens of some mice. Thus, while 
the analysis of SLO will aid our under-
standing of the prevalence prion diseases,114 
such tests may be much less sensitive when 
used on elderly patients and livestock.
Conclusions
Recent advances in the study of the spread 
of prions to the brain suggest that after 
oral exposure neuroinvasion occurs via an 
elegant cellular relay (Fig. 5). After inges-
tion of a contaminated meal, prions appear 
to be actively transcytosed across the FAE 
from the gut lumen by M cells and FAE 
enterocytes.33 However, in the absence of 
M cells neuroinvasion is blocked.66 Once 
the prions have crossed the epithelium 
they are subsequently acquired by MNP 
(macrophages and classical DC). Current 
hypotheses suggest classical DC, in con-
trast to macrophages, act as Trojan horses 
and carry the prions onwards to the FDC 
in the B-cell follicles.77-79 The prions then 
infect and replicate upon FDC which are 
considered to amplify the prions above 
the threshold level required for neuroin-
vasion.10 Following their expansion upon 
FDC, prions subsequently infect neigh-
boring nerve fibers of the enteric nervous 
system.33 Prions are mainly considered to 
spread to the CNS via the peripheral ner-
vous system,11,49 (sympathetic and para-
sympathetic) although it is plausible that 
under some circumstances the hematoge-
nous route may provide a parallel pathway 
of neuroinvasion.
Multiple factors other than the prion 
protein genotype of the host have been 
shown to significantly influence prion 
disease susceptibility, such as the effects 
of aging on the microarchitecture of the 
SLO.34,97 Studies show chronic inflamma-
tion may enhance prion uptake or expand 
their tissue distribution.7,28,115 Bacterial 
colitis also influences oral prion suscepti-
bility.116 Infection with certain pathogenic 
bacteria has been shown to affect the 
density of M cells within the gut epithe-
lium.117,118 Therefore, it is plausible that an 
expansion of M cells induced by concur-
rent infection with an intestinal pathogen 
prions including CWD or BSE. These 
data illustrate how continued surveillance 
of SLO will be important to provide a 
realistic measure of the incidence of pre-
clinical prion disease or “silent carriers,” 
within populations.
Analysis of the spleens and brains of 
prion-exposed aged mice likewise revealed 
that there was considerable variation in 
the detection of prions in the spleens of 
the clinically-negative aged survivors.34,97 
While host age may represent an impor-
tant barrier to the efficient transmission of 
peripherally acquired prion disease, data 
from these studies also suggest that there 
may be significant levels of subclinical 
The detection of prions in blood,108 or 
lymphoid tissue biopsy specimens such 
as tonsils, appendix,19,109 and rectal-asso-
ciated lymphoid follicles,110-113 have each 
been considered as useful preclinical diag-
nostics. Using transgenic mice express-
ing the ovine or human form of PrPC, a 
recent study compared the ability of brain 
and SLO to replicate foreign, inefficiently 
transmitted prions. This might occur fol-
lowing the transmission of a prion disease 
between different species (termed “the 
species barrier”).114 The SLO in these 
transgenic mice were found to be consis-
tently and markedly more permissive than 
the brain to cross-species infection with 
Figure 4. the microarchitecture of the splenic MZ is disrupted in the spleens of aged mice. Left-
hand-parts: in the spleens of young mice MaDCaM1-expressing sinus-lining cells form a distinct 
barrier between the MZ and the white pulp (wP, arrow). rP, red pulp; Fol, FDC-containing B-cell 
follicle. within the MZ abundant CD1d-expressing MZ B cells (upper parts, green) continually 
shuttle between MZ and B-cell follicles as they transfer immune complexes to FDC. two distinct 
populations of macrophages also reside in the MZ: SiGNr1-expressing MZ macrophages and Si-
GLEC1/CD169-expressing MZ metallophilic macrophages (middle and lower parts, brown). in the 
spleens of aged mice the distribution and density of these cells are all severely disrupted when 
compared with young mice (right-hand parts). Upper parts: scale bar = 50 μm; middle and lower 
parts: scale bar = 100 μm. adapted from Brown et al.34
www.landesbioscience.com Prion 329
Figure 5. a potential cellular relay that mediates prion neuroinvasion after oral exposure. after ingestion of a contaminated meal, prions appear to 
be actively transcytosed into Peyer’s patches by M cells and enterocytes in the follicle-associated epithelium. in the absence of M cells neuroinvasion 
is blocked suggesting that M cells are the important sites of prion uptake from the gut lumen. the prions are subsequently acquired by mononuclear 
phagocytes (macrophages and classical DC) in the sub-epithelial dome of the Peyer’s patches. Current hypotheses suggest classical DC, in contrast to 
macrophages, act as trojan horses and carry the prions to the FDC in the B cell follicles. the prions then infect and replicate upon FDC. Following their 
expansion upon FDC, prions subsequently infect enteric nerves. the prions then spread to the CNS via the peripheral nervous system (both sympa-
thetic and parasympathetic).
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identify important targets for therapeutic 
intervention, or alternatively, reveal addi-
tional processes that influence disease sus-
ceptibility to peripherally-acquired prion 
diseases.
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the tongue or nasal cavity, implying direct 
infection of the nervous system.120,124 
Further studies are clearly necessary to 
determine whether inhalation represents 
a significant natural route of prion trans-
mission in domestic and free-ranging 
ruminants.
Finally, although significant progress 
has been made in our understanding of 
how some prion diseases establish infec-
tion within the SLO, little is known of how 
they subsequently infect the peripheral 
nervous system. A thorough understand-
ing of this key event in neuroinvasion may 
or inflammatory stimuli may also influ-
ence oral prion susceptibility.
Recently, exposure via the nasal 
cavity has been proposed as another 
potentially important route of prion trans-
mission.119-121 Furthermore, high levels of 
prions have been reported in the olfactory 
sensory epithelium.122,123 Furthermore, 
prions appear to be shed from the olfac-
tory mucosa of affected animals.122,123 
Interestingly, despite the presence of FDC 
within the nasal-associated lymphoid tis-
sues, prion neuroinvasion appears to occur 
independently of SLO after exposure via 
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